Skip to main content

APLT

Stock
Health Care
Biotechnology

Performance overview

APLT Price
Price Chart

Forward-looking statistics

Beta
1.59
Risk
100.00%

Detailed forecast

[disclaimer]

Individual forecast components (weighted-sum)

Company Profile

applied therapeutics, inc. is a hospital and health care company located in 3104 cherry palm dr, tampa, fl, united states.

Company info

SectorHealth Care
IndustryBiotechnology
Employees28
Market cap$533.6M

Fundamentals

Enterprise value-$4.0M
Revenue$265.0K
Revenue per employee—
Profit margin0.00%
Debt to equity7.36

Security info

ExchangeNASDAQ
Type of shareCommon Stock
Earnings per share (EPS)-$0.24
Dividend per share—
Revenue per share$0.00
Avg trading volume (30 day)$1M
Avg trading volume (10 day)$2M
Put-call ratio—

Macro factor sensitivity

Growth+1.3
Credit+5.7
Liquidity+0.4
Inflation-0.0
Commodities-2.9
Interest Rates-2.5

Valuation

Dividend yield0.00%
PEG Ratio-0.70
Price to sales170.96
P/E Ratio-0.70
Enterprise Value to Revenue-15.16
Price to book1.24

Upcoming events

Next earnings dayMay 14, 2025
Next dividend day—
Ex. dividend day—

News

Regulatory Setback For Applied Therapeutics' Lead Program, FDA Highlights Deficiencies In Clinical Application

On Wednesday, Applied Therapeutics, Inc APLT received an FDA Complete Response Letter (CRL) for the New Drug Application (NDA) for govorestat for Classic Galactosemia.

Benzinga (November 29, 2024)
APLT Stock Plunges 77% After FDA Issues CRL for Galactosemia Drug NDA

Applied Therapeutics stock plummets 77% after the FDA issues a CRL for the company's NDA seeking approval for govorestat to treat classic galactosemia.

Zacks Investment Research (November 28, 2024)

Unlock Personalized Financial Tools

All our core financial tools are completely free. Create an account to save your research, get personalized recommendations, and enjoy unlimited access.

Save research to draft portfolios
Get personalized recommendations
Access unlimited tool usage
Sign up for free